Zeng G; Penninkilampi R; Chaganti J; Montagnese S; Brew BJ; Danta M, 2020, 'Meta-analysis of magnetic resonance spectroscopy in the diagnosis of hepatic encephalopathy.',
Neurology, vol. 94, pp. e1147 - e1156,
http://dx.doi.org/10.1212/WNL.00000000000088992020
Bukhari W; Clarke L; O’Gorman C; Khalilidehkordi E; Arnett S; Prain KM; Woodhall M; Silvestrini R; Bundell CS; Ramanathan S; Abernethy D; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brownlee W; Butzkueven H; Carroll WM; Chen C; Coulthard A; Dale RC; Das C; Dear K; Fabis-Pedrini MJ; Fulcher D; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Jimenez-Sanchez S; Kilpatrick TJ; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonnell RAL; Mason DF; McCombe PA; Pereira J; Pollard JD; Reddel SW; Shaw C; Spies J; Stankovich J; Sutton I; Vucic S; Walsh M; Wong RC; Yiu EM; Barnett MH; Kermode AG; Marriott MP; Parratt J; Slee M; Taylor BV; Willoughby E; Wilson RJ; Brilot F; Vincent A; Waters P; Broadley SA, 2020, 'The clinical profile of NMOSD in Australia and New Zealand',
Journal of Neurology,
http://dx.doi.org/10.1007/s00415-020-09716-42020
Aung HL; Kootar S; Gates TM; Brew BJ; Cysique LA, 2019, 'How all-type dementia risk factors and modifiable risk interventions may be relevant to the first-generation aging with HIV infection?',
European Geriatric Medicine, vol. 10, pp. 227 - 238,
http://dx.doi.org/10.1007/s41999-019-00164-62019
Jacobs KR; Lim CK; Blennow K; Zetterberg H; Chatterjee P; Martins RN; Brew BJ; Guillemin GJ; Lovejoy DB, 2019, 'Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tau',
Neurobiology of Aging, vol. 80, pp. 11 - 20,
http://dx.doi.org/10.1016/j.neurobiolaging.2019.03.0152019
Cysique LA; Jugé L; Lennon MJ; Gates TM; Jones SP; Lovelace MD; Rae CD; Johnson TP; Nath A; Brew BJ, 2019, 'HIV brain latency as measured by CSF BcL11b relates to disrupted brain cellular energy in virally suppressed HIV infection',
AIDS, vol. 33, pp. 433 - 441,
http://dx.doi.org/10.1097/QAD.00000000000020762019
Chaganti J; Marripudi K; Staub LP; Rae CD; Gates TM; Moffat KJ; Brew BJ, 2019, 'Imaging correlates of the blood-brain barrier disruption in HIV-associated neurocognitive disorder and therapeutic implications',
AIDS, vol. 33, pp. 1843 - 1852,
http://dx.doi.org/10.1097/QAD.00000000000023002019
Asahchop EL; Branton WG; Krishnan A; Chen PA; Yang D; Kong L; Zochodne DW; Brew BJ; Gill MJ; Power C, 2018, 'HIV-associated sensory polyneuropathy and neuronal injury are associated with miRNA-455-3p induction',
JCI insight, vol. 3,
http://dx.doi.org/10.1172/jci.insight.1224502018
Anderson AM; Croteau D; Ellis RJ; Rosario D; Potter M; Guillemin GJ; Brew BJ; Woods SP; Letendre SL, 2018, 'HIV, prospective memory, and cerebrospinal fluid concentrations of quinolinic acid and phosphorylated Tau',
Journal of Neuroimmunology, vol. 319, pp. 13 - 18,
http://dx.doi.org/10.1016/j.jneuroim.2018.03.0072018
Wright EJ; Grund B; Robertson KR; Cysique L; Brew BJ; Collins GL; Poehlman-Roediger M; Vjecha MJ; Penalva De Oliveira AC; Standridge B; Carey C; Avihingsanon A; Florence E; Lundgren JD; Arenas-Pinto A; Mueller NJ; Winston A; Nsubuga MS; Lal L; Price RW, 2018, 'No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4
+ T-cell counts',
AIDS, vol. 32, pp. 985 - 997,
http://dx.doi.org/10.1097/QAD.00000000000017782018
Warhurst S; Rofe CJ; Brew BJ; Bateson D; McGeechan K; Merki-Feld GS; Garrick R; Tomlinson SE, 2018, 'Effectiveness of the progestin-only pill for migraine treatment in women: A systematic review and meta-analysis',
Cephalalgia, vol. 38, pp. 754 - 764,
http://dx.doi.org/10.1177/03331024177106362018
Cysique LA; Jugé L; Gates T; Tobia M; Moffat K; Brew BJ; Rae C, 2018, 'Covertly active and progressing neurochemical abnormalities in suppressed HIV infection',
Neurology: Neuroimmunology and NeuroInflammation, vol. 5,
http://dx.doi.org/10.1212/NXI.00000000000004302018
Radd-Vagenas S; Duffy SL; Naismith SL; Brew BJ; Flood VM; Fiatarone Singh MA, 2018, 'Effect of the Mediterranean diet on cognition and brain morphology and function: A systematic review of randomized controlled trials',
American Journal of Clinical Nutrition, vol. 107, pp. 389 - 404,
http://dx.doi.org/10.1093/ajcn/nqx0702018
Haggstrom L; Brew B; Sutton I; Tisch S, 2018, 'Vestibular symptoms as the presenting feature of progressive supranuclear palsy',
Journal of Clinical Neuroscience, vol. 50, pp. 74 - 76,
http://dx.doi.org/10.1016/j.jocn.2018.01.0212018
Bundell C; Brunt SJ; Cysique LA; Brusch A; Brew BJ; Price P, 2018, 'The high frequency of autoantibodies in HIV patients declines on antiretroviral therapy',
Pathology, vol. 50, pp. 313 - 316,
http://dx.doi.org/10.1016/j.pathol.2017.10.0172018
Nichols M; Gates T; Soares J; Moffat K; Rae C; Brew B; Cysique L, 2018, 'Brain atrophic signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection',
AIDS, vol. 33, pp. 55 - 66,
http://dx.doi.org/10.1097/QAD.00000000000020422018
Wilson MR; O'Donovan BD; Gelfand JM; Sample HA; Chow FC; Betjemann JP; Shah MP; Richie MB; Gorman MP; Hajj-Ali RA; Calabrese LH; Zorn KC; Chow ED; Greenlee JE; Blum JH; Green G; Khan LM; Banerji D; Langelier C; Bryson-Cahn C; Harrington W; Lingappa JR; Shanbhag NM; Green AJ; Brew BJ; Soldatos A; Strnad L; Doernberg SB; Jay CA; Douglas V; Josephson SA; DeRisi JL, 2018, 'Chronic meningitis investigated via metagenomic next-generation sequencing',
JAMA Neurology, vol. 75, pp. 947 - 955,
http://dx.doi.org/10.1001/jamaneurol.2018.04632018
Chaganti JR; Heinecke A; Gates TM; Moffat KJ; Brew BJ, 2017, 'Functional connectivity in virally suppressed patients with HIV-associated neurocognitive disorder: A resting-state analysis',
American Journal of Neuroradiology, vol. 38, pp. 1623 - 1629,
http://dx.doi.org/10.3174/ajnr.A52462017
Lee JM; Tan V; Lovejoy D; Braidy N; Rowe DB; Brew BJ; Guillemin GJ, 2017, 'Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis',
Neuropharmacology, vol. 112, pp. 346 - 364,
http://dx.doi.org/10.1016/j.neuropharm.2016.05.0112017
Bukhari W; Prain KM; Waters P; Woodhall M; O'Gorman CM; Clarke L; Silvestrini RA; Bundell CS; Abernethy D; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brown M; Brownlee WJ; Butzkueven H; Carroll WM; Chen C; Coulthard A; Dale RC; Das C; Dear K; Fabis-Pedrini MJ; Fulcher D; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Jimenez-Sanchez S; Killpatrick T; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonell R; Mason DF; McCombe PA; Pender MP; Pereira JA; Pollard JD; Reddel SW; Shaw C; Spies J; Stankovich J; Sutton I; Vucic S; Walsh M; Wong RC; Yiu EM; Barnett MH; Kermode AG; Marriott MP; Parratt JDE; Slee M; Taylor BV; Willoughby E; Wilson RJ; Vincent A; Broadley SA, 2017, 'Incidence and prevalence of NMOSD in Australia and New Zealand',
Journal of Neurology, Neurosurgery and Psychiatry, vol. 88, pp. 632 - 638,
http://dx.doi.org/10.1136/jnnp-2016-3148392017
Cysique LA; Gott C; Gates TM; Dermody N; Brew BJ, 2017, 'Cognitive Change Trajectories in Virally Suppressed HIV-Infected Individuals Indicate High Prevalence of Disease Activity',
PLoS One, vol. 12,
http://dx.doi.org/10.1371/journal.pone.01718872017
Kamminga J; Lal L; Wright EJ; Bloch M; Brew BJ; Cysique LA, 2017, 'Monitoring HIV-Associated Neurocognitive Disorder Using Screenings: a Critical Review Including Guidelines for Clinical and Research Use',
Current HIV/AIDS Reports, vol. 14, pp. 83 - 92,
http://dx.doi.org/10.1007/s11904-017-0349-92017
Lennon MJ; Jones SP; Lovelace MD; Guillemin GJ; Brew BJ, 2017, 'Bcl11b-A critical neurodevelopmental transcription factor-roles in health and disease',
Frontiers in Cellular Neuroscience, vol. 11,
http://dx.doi.org/10.3389/fncel.2017.000892017
Cysique LA; Soares JR; Geng G; Scarpetta M; Moffat K; Green M; Brew BJ; Henry RG; Rae C, 2017, 'Erratum to: White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration (Journal of NeuroVirology, (2017), 23, 4, (539-547), 10.1007/s13365-017-0524-1)',
Journal of NeuroVirology, vol. 23, pp. 548 - 549,
http://dx.doi.org/10.1007/s13365-017-0542-z2017
Cysique LA; Soares JR; Geng G; Scarpetta M; Moffat K; Green M; Brew BJ; Henry RG; Rae C, 2017, 'White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration',
Journal of NeuroVirology, vol. 23, pp. 539 - 547,
http://dx.doi.org/10.1007/s13365-017-0524-12017
Gott C; Gates T; Dermody N; Brew BJ; Cysique LA, 2017, 'Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity',
PLOS ONE, vol. 12,
http://dx.doi.org/10.1371/journal.pone.01718872017
Lovelace MD; Varney B; Sundaram G; Lennon MJ; Lim CK; Jacobs K; Guillemin GJ; Brew BJ, 2017, 'Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases',
Neuropharmacology, vol. 112, pp. 373 - 388,
http://dx.doi.org/10.1016/j.neuropharm.2016.03.0242017
Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA, 2017, 'Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure',
Journal of Clinical and Experimental Neuropsychology, vol. 39, pp. 753 - 767,
http://dx.doi.org/10.1080/13803395.2016.12632822017
Lim CK; Bilgin A; Lovejoy DB; Tan V; Bustamante S; Taylor BV; Bessede A; Brew BJ; Guillemin GJ, 2017, 'Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression',
Scientific Reports, vol. 7,
http://dx.doi.org/10.1038/srep414732017
Crossley KM; Agnihotri S; Chaganti J; Rodriguez ML; McNally LP; Venna N; Turbett SE; Gutman M; Morey A; Koralnik IJ; Brew BJ, 2016, 'Recurrence of progressive multifocal leukoencephalopathy despite immune recovery in two HIV seropositive individuals',
Journal of NeuroVirology, vol. 22, pp. 541 - 545,
http://dx.doi.org/10.1007/s13365-015-0419-y2016
Bloch M; Kamminga J; Jayewardene A; Bailey M; Carberry A; Vincent T; Quan D; Maruff P; Brew B; Cysique LA, 2016, 'A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review',
Clinical Infectious Diseases, vol. 63, pp. 687 - 693,
http://dx.doi.org/10.1093/cid/ciw3992016
Braidy N; Rossez H; Lim CK; Jugder BE; Brew BJ; Guillemin GJ, 2016, 'Characterization of the Kynurenine Pathway in CD8
+ Human Primary Monocyte-Derived Dendritic Cells',
Neurotoxicity Research, vol. 30, pp. 620 - 632,
http://dx.doi.org/10.1007/s12640-016-9657-x2016
Gray LR; Cowley D; Welsh C; Lu HK; Brew BJ; Lewin SR; Wesselingh SL; Gorry PR; Churchill MJ, 2016, 'CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies',
Molecular Psychiatry, vol. 21, pp. 574 - 584,
http://dx.doi.org/10.1038/mp.2015.1112016
Gates TM; Cysique LA; Siefried KJ; Chaganti J; Moffat KJ; Brew BJ, 2016, 'Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder',
AIDS, vol. 30, pp. 591 - 600,
http://dx.doi.org/10.1097/QAD.00000000000009512016
Nadel J; O'Dwyer E; Emmanuel S; Huang J; Cheruvu S; Sammel N; Brew B; Otton J; Holloway CJ, 2016, 'High-risk coronary plaque, invasive coronary procedures, and cardiac events among HIV-positive individuals and matched controls',
Journal of Cardiovascular Computed Tomography, vol. 10, pp. 391 - 397,
http://dx.doi.org/10.1016/j.jcct.2016.07.0182016
Lennon MJ; Jones SP; Lovelace MD; Guillemin GJ; Brew BJ, 2016, 'Bcl11b: A New Piece to the Complex Puzzle of Amyotrophic Lateral Sclerosis Neuropathogenesis?',
Neurotoxicity Research, vol. 29, pp. 201 - 207,
http://dx.doi.org/10.1007/s12640-015-9573-52016
Brunt SJ; Cysique LA; Lee S; Burrows S; Brew BJ; Price P, 2016, 'Short communication: Do cytomegalovirus antibody levels associate with age-related syndromes in HIV patients stable on antiretroviral therapy?',
AIDS Research and Human Retroviruses, vol. 32, pp. 567 - 572,
http://dx.doi.org/10.1089/aid.2015.03282016
Lovelace MD; Varney B; Sundaram G; Franco NF; Ng ML; Pai S; Lim CK; Guillemin GJ; Brew BJ, 2016, 'Current evidence for a role of the kynurenine pathway of tryptophan metabolism in multiple sclerosis',
Frontiers in Immunology, vol. 7,
http://dx.doi.org/10.3389/fimmu.2016.002462016
Anesten B; Yilmaz A; Hagberg L; Zetterberg H; Nilsson S; Brew BJ; Fuchs D; Price RW; Gisslén M, 2016, 'Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV',
Neurology: Neuroimmunology and NeuroInflammation, vol. 3,
http://dx.doi.org/10.1212/NXI.00000000000003002016
Cysique LA; Dermody N; Carr A; Brew BJ; Teesson M, 2016, 'The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults',
Journal of NeuroVirology, vol. 22, pp. 56 - 65,
http://dx.doi.org/10.1007/s13365-015-0368-52016
Britton PN; Eastwood K; Brew BJ; Nagree Y; Jones CA, 2015, 'Consensus guidelines for the investigation and management of encephalitis',
Medical Journal of Australia, vol. 202, pp. 576 - 577,
http://dx.doi.org/10.5694/mja14.010422015
Brew BJ; Robertson K; Wright EJ; Churchill M; Crowe SM; Cysique LA; Deeks S; Garcia JV; Gelman B; Gray LR; Johnson T; Joseph J; Margolis DM; Mankowski JL; Spencer B, 2015, 'HIV eradication symposium: will the brain be left behind?',
Journal of NeuroVirology, vol. 21, pp. 322 - 334,
http://dx.doi.org/10.1007/s13365-015-0322-62015
Inder KJ; Hussain R; Allen J; Brew B; Lewin TJ; Attia J; Kelly BJ, 2015, 'Factors associated with personal hopefulness in older rural and urban residents of New South Wales',
Advances in Mental Health, vol. 13, pp. 43 - 57,
http://dx.doi.org/10.1080/18374905.2015.10391862015
Jones SP; Franco NF; Varney B; Sundaram G; Brown DA; De Bie J; Lim CK; Guillemin GJ; Brew BJ, 2015, 'Expression of the kynurenine pathway in human peripheral blood mononuclear cells: Implications for inflammatory and neurodegenerative disease',
PLoS ONE, vol. 10,
http://dx.doi.org/10.1371/journal.pone.01313892015
Britton PN; Eastwood K; Paterson B; Durrheim DN; Dale RC; Cheng AC; Kenedi C; Brew BJ; Burrow J; Nagree Y; Leman P; Smith DW; Read K; Booy R; Jones CA, 2015, 'Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and New Zealand',
Internal Medicine Journal, vol. 45, pp. 563 - 576,
http://dx.doi.org/10.1111/imj.127492015
Wright EJ; Grund B; Cysique LA; Robertson KR; Brew BJ; Collins G; Shlay JC; Winston A; Read TRH; Price RW, 2015, 'Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial',
HIV MEDICINE, vol. 16, pp. 97 - 108,
http://dx.doi.org/10.1111/hiv.122382015
Cysique LA; Hewitt T; Croitoru-Lamoury J; Taddei K; Martins RN; Chew CSN; Davies NNWS; Price P; Brew BJ, 2015, 'APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - A cross-sectional observational study',
BMC Neurology, vol. 15,
http://dx.doi.org/10.1186/s12883-015-0298-02015
Cysique LA; Dermody N; Carr A; Brew BJ; Teesson M, 2015, 'The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults',
Journal of NeuroVirology, vol. 22, pp. 56 - 65,
http://dx.doi.org/10.1007/s13365-015-0368-52015
Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RA; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies JM; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E, 2015, 'A new era in the treatment of multiple sclerosis',
Medical Journal of Australia, vol. 203, pp. 139 - 141,
http://dx.doi.org/10.5694/mja14.012182015
Cysique LA; Hey-Cunningham WJ; Dermody N; Chan P; Brew BJ; Koelsch KK, 2015, 'Peripheral blood mononuclear cells HIV DNA levels impact intermittently on neurocognition',
PLoS ONE, vol. 10,
http://dx.doi.org/10.1371/journal.pone.01204882015
Lundgren J; Babiker A; Gordin F; Emery S; Fätkenheuer G; Molina JM; Wood R; Neaton JD; Agan BK; Alston-Smith B; Arenas-Pinto A; Arribas JR; Baker JV; Baxter J; Belloso WH; Brekke K; Brew B; Brobst SW; Burman W; Carey C; Clark R; Cooper DA; Davey RT; De La Rosa G; Denning ET; Dolan M; Dore G; Duprez D; Emanuel E; Grady C; Grund B; Hirschel B; Hoen B; Hudson F; Johnson MA; Kambili C; Klingman K; Kunisaki KM; Landay A; Ledergerber B; Lehrman SN; Martinez A; Meger S; Misar K; Mitsuyasu RT; Mocroft A; Munroe D; Norton M; Palmer RC; Pett SL; Phillips A; Pillay D; Porter D; Price RW; Proschan M; Rappoport C; Reiss P; Renjifo B; Robertson K; Rockstroh J; Rodriguez G; Rooney JF; Ross MJ; Schechter M; Schwarze S; Seekins D; Sharma S; Snowden W; Telenti A; Tryon J; van Wyk J; Vjecha MJ; Wright E, 2015, 'Why START? Reflections that led to the conduct of this large long-term strategic HIV trial',
HIV Medicine, vol. 16, pp. 1 - 9,
http://dx.doi.org/10.1111/hiv.122272015
Watts J; Brew B; Tisch S, 2015, 'Myasthenia gravis exacerbation with low dose ocular botulinum toxin for epiphoria',
Journal of Clinical Neuroscience, vol. 22, pp. 1979 - 1981,
http://dx.doi.org/10.1016/j.jocn.2015.05.0322015
Calic Z; Cappelen-Smith C; Hodgkinson SJ; McDougall A; Cuganesan R; Brew BJ, 2015, 'Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab',
Journal of Clinical Neuroscience, vol. 22, pp. 598 - 600,
http://dx.doi.org/10.1016/j.jocn.2014.08.0162015
Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RAL; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E, 2014, 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies',
Journal of Clinical Neuroscience, vol. 21, pp. 1835 - 1846,
http://dx.doi.org/10.1016/j.jocn.2014.01.0162014
Lu GM; Brew BJ; Siefried KJ; Draper B; Cysique LA, 2014, 'Is the HIV dementia scale a reliable tool for assessing HIV-relatedneurocognitive decline?',
Journal of AIDS and Clinical Research, vol. 5,
http://dx.doi.org/10.4172/2155-6113.10002692014
Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RAL; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E, 2014, 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy',
Journal of Clinical Neuroscience, vol. 21, pp. 1847 - 1856,
http://dx.doi.org/10.1016/j.jocn.2014.01.0182014
Dwyer R; Wenhui L; Cysique L; Brew BJ; Lal L; Bain P; Wesselingh S; Wright EJ, 2014, 'Symptoms of depression and rates of neurocognitive impairment in HIV positive patients in Beijing, China',
Journal of Affective Disorders, vol. 162, pp. 89 - 95,
http://dx.doi.org/10.1016/j.jad.2014.03.0382014
Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ, 2014, 'Involvement of the Kynurenine Pathway in Human Glioma Pathophysiology',
PLOS ONE, vol. 9,
http://dx.doi.org/10.1371/journal.pone.01129452014
Cysique LA; Brew BJ, 2014, 'The effects of HIV and aging on brain functions: Proposing a research framework and update on last 3 years' findings',
Current Opinion in HIV and AIDS, vol. 9, pp. 355 - 364,
http://dx.doi.org/10.1097/COH.00000000000000782014
Sundaram G; Brew BJ; Jones SP; Adams S; Lim CK; Guillemin GJ, 2014, 'Quinolinic acid toxicity on oligodendroglial cells: Relevance for multiple sclerosis and therapeutic strategies',
Journal of Neuroinflammation, vol. 11,
http://dx.doi.org/10.1186/s12974-014-0204-52014
Chan P; Brew BJ, 2014, 'HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment',
Current HIV/AIDS reports, vol. 11, pp. 317 - 324,
http://dx.doi.org/10.1007/s11904-014-0221-02014
Cysique LA; Heaton RK; Kamminga J; Lane T; Gates TM; Moore DM; Hubner E; Carr A; Brew BJ, 2014, 'HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research',
Journal of NeuroVirology, vol. 20, pp. 258 - 268,
http://dx.doi.org/10.1007/s13365-014-0242-x2014
Braidy N; Brew BJ; Inestrosa NC; Chung R; Sachdev P; Guillemin GJ, 2014, 'Changes in Cathepsin D and Beclin-1 mRNA and protein expression by the excitotoxin quinolinic acid in human astrocytes and neurons',
Metabolic brain disease, vol. 29, pp. 873 - 883,
http://dx.doi.org/10.1007/s11011-014-9557-92014
Chan P; Brew BJ, 2014, 'HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment',
Current HIV/AIDS reports, vol. 11, pp. 317 - 324,
http://dx.doi.org/10.1007/s11904-014-0221-02014
Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RAL; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E, 2014, 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations',
Journal of Clinical Neuroscience, vol. 21, pp. 1857 - 1865,
http://dx.doi.org/10.1016/j.jocn.2014.01.0172014
Antinori A; Arendt G; Grant I; Letendre S; Muñoz-Moreno JA; Eggers C; Brew B; Brouillette MJ; Bernal-Cano F; Carvalhal A; Christo PP; Cinque P; Cysique L; Ellis R; Everall I; Gasnault J; Husstedt I; Korten V; Machala L; Obermann M; Ouakinin S; Podzamczer D; Portegies P; Rackstraw S; Rourke S; Sherr L; Streinu-Cercel A; Winston A; Wojna V; Yazdanpannah Y; Arbess G; Baril JG; Begovac J; Bergin C; Bonfanti P; Bonora S; Brinkman K; Canestri A; Cholewinska-Szymanska G; Chowers M; Cooney J; Corti M; Doherty C; Elbirt D; Esser S; Florence E; Force G; Gill J; Goffard JC; Harrer T; Li P; Van De Kerckhove L; Knecht G; Matsushita S; Matulionyte R; McConkey S; Mouglignier A; Oka S; Penalva A; Riesenberg K; Sambatakou H; Tozzi V; Vassallo M; Wetterberg P; Drapato AW, 2013, 'Assessment, diagnosisand treatment of Human Immunodeficiency Virus (HIV)-associated neurocognitive disorders (HAND): A consensus report of the mind exchange program',
Clinical Infectious Diseases, vol. 56, pp. 1004 - 1017,
http://dx.doi.org/10.1093/cid/cis9752013
Clifford DB; Nath A; Cinque P; Brew BJ; Zivadinov R; Gorelik L; Zhao Z; Duda P, 2013, 'A study of mefloquine treatment for progressive multifocal leukoencephalopathy: Results and exploration of predictors of PML outcomes',
Journal of NeuroVirology, vol. 19, pp. 351 - 358,
http://dx.doi.org/10.1007/s13365-013-0173-y2013
Brown S; Simpson DM; Moyle G; Brew BJ; Schifitto G; Larbalestier N; Orkin C; Fisher M; Vanhove GF; Tobias JK, 2013, 'NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: Integrated analysis of two phase III, randomized, controlled trials',
AIDS Research and Therapy, vol. 10,
http://dx.doi.org/10.1186/1742-6405-10-52013
Peluso MJ; Meyerhoff DJ; Price RW; Peterson J; Lee E; Young AC; Walter R; Fuchs D; Brew BJ; Cinque P; Robertson K; Hagberg L; Zetterberg H; Gisslén M; Spudich S, 2013, 'Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection',
Journal of Infectious Diseases, vol. 207, pp. 1703 - 1712,
http://dx.doi.org/10.1093/infdis/jit0882013
Braidy N; Lim CK; Grant R; Brew BJ; Guillemin GJ, 2013, 'Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis',
Brain Research, vol. 1537, pp. 267 - 272,
http://dx.doi.org/10.1016/j.brainres.2013.08.0252013
Grund B; Wright EJ; Brew BJ; Price RW; Roediger MP; Bain MP; Hoy JF; Shlay JC; Vjecha MJ; Robertson KR, 2013, 'Improved neurocognitive test performance in both arms of the SMART study: Impact of practice effect',
Journal of NeuroVirology, vol. 19, pp. 383 - 392,
http://dx.doi.org/10.1007/s13365-013-0190-x2013
Sasson SC; Oon A; Chagantri J; Brew BJ; Carr A, 2013, 'Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: a case report',
BMC Infectious Diseases, vol. 13, pp. 396 - 396,
http://dx.doi.org/10.1186/1471-2334-13-3962013
Kamminga J; Cysique LA; Lu G; Batchelor J; Brew BJ, 2013, 'Validity of Cognitive Screens for HIV-Associated Neurocognitive Disorder: A Systematic Review and an Informed Screen Selection Guide',
Current HIV/AIDS Reports, vol. 10, pp. 342 - 355,
http://dx.doi.org/10.1007/s11904-013-0176-62013
Joseph J; Achim CL; Boivin MJ; Brew BJ; Clifford DB; Colosi DA; Ellis RJ; Heaton RK; Gallo-Diop A; Grant I; Kanmogne GD; Kumar M; Letendre S; Marcotte TD; Nath A; Pardo CA; Paul RH; Pulliam L; Robertson K; Royal W; Sacktor N; Sithinamsuwan P; Smith DM; Valcour V; Wigdahl B; Wood C, 2013, 'Global NeuroAIDS roundtable',
Journal of NeuroVirology, vol. 19, pp. 1 - 9,
http://dx.doi.org/10.1007/s13365-012-0143-92013
LeWitt PA; Boroojerdi B; Surmann E; Poewe W, 2013, 'Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER',
JOURNAL OF NEURAL TRANSMISSION, vol. 120, pp. 1069 - 1081,
http://dx.doi.org/10.1007/s00702-012-0925-52013
Brew BJ; McLean CA; Major EO, 2013, 'Progressive multifocal leukoencephalopathy caused by BK virus?',
Medical Journal of Australia, vol. 198, pp. 179 - 180,
http://dx.doi.org/10.5694/mja12.117982013
Jones SP; Guillemin GJ; Brew BJ, 2013, 'The kynurenine pathway in stem cell biology',
International Journal of Tryptophan Research, vol. 6, pp. 57 - 66,
http://dx.doi.org/10.4137/IJTR.S126262013
Wu W; Nicolazzo JA; Wen L; Chung RS; Stankovic RK; Bao SS; Lim CKE; Brew BJ; Cullen KM; Guillemin GJ, 2013, 'Expression of Tryptophan 2,3-Dioxygenase and Production of Kynurenine Pathway Metabolites in Triple Transgenic Mice and Human Alzheimer's Disease Brain',
PLoS One, vol. 8, pp. Article numbere59749,
http://dx.doi.org/10.1371/journal.pone.00597492013
Adams S; Braidy N; Bessede A; Brew BJ; Grant R; Teo C; Guillemin GJ, 2012, 'Correction: The kynurenine pathway in brain tumor pathogenesis (Cancer Research (2012) 72, (5649-5657))',
Cancer Research, vol. 72, pp. 6524,
http://dx.doi.org/10.1158/0008-5472.CAN-12-42302012
Clifford D; Simpson D; Brown S; Moyle G; Brew BJ; Conway B; Tobias J; Vanhove J, 2012, 'A Randomized, Double-Blind, Controlled Study of NGX-4010, a Capsaicin 8% Dermal Patch, for the Treatment of Painful HIV-Associated Distal Sensory Polyneuropathy',
JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 59, pp. 126 - 133,
http://dx.doi.org/10.1097/QAI.0b013e31823e31f72012
Lane TA; Batchelor J; Brew BJ; Cysique LA, 2012, 'Facial emotional processing in HIV infection: relation to neurocognitive and neuropsychiatric status',
Neuropsychology, vol. 26, pp. 713 - 722,
http://dx.doi.org/10.1037/a00299642012
Cruse B; Cysique LA; Markus R; Brew BJ, 2012, 'Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy',
Journal of Neurovirology, vol. 18, pp. 264 - 276,
http://dx.doi.org/10.1007/s13365-012-0092-32012
Lim CK; Yap MMC; Kent SJ; Gras G; Samah B; Batten JC; De Rose R; Heng B; Brew BJ; Guillemin GJ, 2012, 'Characterization of the Kynurenine pathway and quinolinic acid production in macaque macrophages',
International Journal of Tryptophan Research, vol. 6, pp. 7 - 19,
http://dx.doi.org/10.4137/IJTR.S117892012
Cysique LA; Waters EK; Brew BJ, 2011, 'Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research',
BMC NEUROLOGY, vol. 11, pp. 148 - 158,
http://dx.doi.org/10.1186/1471-2377-11-1482011
Botes LP; Jin F; Bourne CP; Pett SL; Marriott D; Carr AD; Cooper DA; Matthews G; Brew BJ; Hillman R, 2011, 'Participants' perspectives of self-collected anal cytological swabs',
Sexual Health, vol. 8, pp. 257 - 258,
http://dx.doi.org/10.1071/SH100372011
Croitoru-Lamoury J; Lamoury F; Caristo M; Suzuki K; Walker DW; Takikawa O; Taylor R; Brew BJ, 2011, 'Interferon-c Regulates the Proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO)',
PLoS One, vol. 6, pp. 1 - 13,
http://dx.doi.org/10.1371/journal.pone.00146982011
Cysique LA; Bain MP; Brew BJ; Murray JM, 2011, 'The burden of HIV-associated neurocognitive impairment in Australia and its estimates for the future',
Sexual Health, vol. 8, pp. 541 - 550,
http://dx.doi.org/10.1071/SH110032011
Tippett M; Cheng W; Westhorpe R; Cameron A; Brew BJ; Lewin S; Jaworowski A; Crowe S, 2011, 'Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals',
PLoS One, vol. 6, pp. 1 - 11,
http://dx.doi.org/10.1371/journal.pone.00199682011
Ng K; Kumar KR; Brew BJ; Burke D, 2011, 'Axonal excitability in viral polyneuropathy and nucleoside neuropathy in HIV patients',
Journal of Neurology Neurosurgery and Psychiatry, vol. 82, pp. 978 - 980,
http://dx.doi.org/10.1136/jnnp.2009.2030912011
Hillman R; Pett SL; Marriott D; Carr AD; Cooper DA; Matthews GV; Brew BJ; Milliken S; Botes LP, 2011, 'Participants' perspectives of high resolution anoscopy',
Sexual Health, vol. 8, pp. 255 - 256,
http://dx.doi.org/10.1071/SH101162011
Spudich S; Gisslen M; Hagberg L; Lee E; Liegler T; Brew BJ; Fuchs A; Tambussi G; Cinque P; Hecht FM; Price R, 2011, 'Central nervous system immune activation characterizes primary HIV-1 infection even in subjects with minimal cerebrospinal fluid viral burden',
Journal of Infectious Diseases, vol. 204, pp. 753 - 760,
http://dx.doi.org/10.1093/infdis/jir3872011
McManus H; Lim P; Nolan D; Bloch M; Kiertiburanakul S; Choi J; Mulhall BP; Petoumenos K; Zhou J; Law MG; Brew BJ; Wright E, 2011, 'Does use of antiretroviral therapy regimens with high central nervous system penetration improve survival in HIV-infected adults?',
HIV Medicine, vol. 12, pp. 610 - 619,
http://dx.doi.org/10.1111/j.1468-1293.2011.00938.x2011
Maher A; Cysique LA; Brew BJ; Rae CD, 2011, 'Statistical integration of 1H NMR and MRS data from difefrent biofluids and tissues enhances recovery of biological information from individuals with HIV-1 infection',
Journal of Proteome Research, vol. 10, pp. 1737 - 1745,
http://dx.doi.org/10.1021/pr10102632011
Dunbar M; Murray JM; Cysique LA; Brew BJ; Jeyakumar V, 2010, 'Simultaneous classification and feature selection via convex quadratic programming with application to HIV-associated neurocognitive disorder assessment',
European Journal of Operational Research, vol. 206, pp. 470 - 478,
http://dx.doi.org/10.1016/j.ejor.2010.03.0172010
Brew BJ, 2010, 'Benefit or toxicity from neurologically targeted antiretroviral therapy?',
Clinical Infectious Diseases, vol. 50, pp. 930 - 932,
http://dx.doi.org/10.1086/6507442010
Lim CK; Brew BJ; Sundaram G; Guillemin GJ, 2010, 'Understanding the roles of the kynurenine pathway in multiple sclerosis progression', International Journal of Tryptophan Research, vol. 3, pp. 157 - 167
2010
Davies NWS; Guillemin G; Brew BJ, 2010, 'Tryptophan, neurodegeneration and HIV-associated neurocognitive disorder', International Journal of Tryptophan Research, vol. 3, pp. 121 - 140
2010
Lifson A; Belloso W; Davey R; Duprez D; Gatell J; Hoy J; Krum E; Nelson R; Pedersen C; Perez G; Price R; Prineas R; Rhame F; Sampson J; Worley J, 2010, 'Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials',
HIV Clinical Trials, vol. 11, pp. 205 - 219,
http://dx.doi.org/10.1310/hct1104-2052010
Tisch S; Brew BJ, 2010, 'HIV, HAART, and parkinson's disease: Co-incidence or pathogenetic link?',
Movement Disorders, vol. 25, pp. 2257 - 2258,
http://dx.doi.org/10.1002/mds.232772010
Cherry CL; Affandi JS; Brew BJ; Creighton J; Djauzi S; Hooker DJ; Imran D; Kamarulzaman A; Kamerman P; McArthur JC; Moore RD; Price P; Smyth K; Tan IL; Vanar S; Wadley A; Wesselingh SL; Yunihastuti E, 2010, 'Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV',
Neurology, vol. 74, pp. 1538 - 1542,
http://dx.doi.org/10.1212/WNL.0b013e3181dd436d2010
Zhou L; Diefenbach E; Crossett B; Tran SL; Ng T; Rizos H; Rua R; Wang B; Kapur A; Gandhi K; Brew BJ; Saksena NK, 2010, 'First evidence of overlaps between HIV-associated dementia (HAD) and non-viral neurodegenerative diseases: Proteomic analysis of the frontal cortex from HIV+ patients with and without dementia',
Molecular Neurodegeneration, vol. 5,
http://dx.doi.org/10.1186/1750-1326-5-272010
Hagberg L; Cinque P; Gisslen M; Brew BJ; Spudich S; Bestetti A; Price RW; Fuchs D, 2010, 'Cerebrospinal fluid neopterin: An informative biomarker of central nervous system immune activation in HIV-1 infection',
AIDS Research and Therapy, vol. 7,
http://dx.doi.org/10.1186/1742-6405-7-152010
Brew BJ; Davies NWS; Cinque P; Clifford D; Nath A, 2010, 'Progressive multifocal leukoencephalopathy and other forms of JC virus disease',
Nature Reviews Neuroscience, vol. 6, pp. 667 - 679,
http://dx.doi.org/10.1038/nrneurol.2010.1642010
Rahman A; Ting K; Cullen KM; Braidy N; Brew BJ; Guillemin GJ, 2009, 'The excitotoxin quinolinic acid induces tau phosphorylation in human neurons',
PLoS One, vol. 4, pp. e6344 -1 - 15,
http://dx.doi.org/10.1371/journal.pone.00063442009
Gray L; Roche M; Churchill MJ; Sterjovski J; Ellett A; Poumbourios P; Sheffief S; Wang B; Saksena N; Purcell DFJ; Wesselingh S; Cunningham AL; Brew BJ; Gabuzda D; Gorry PR, 2009, 'Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain',
Journal of Virology, vol. 83, pp. 5430 - 5441,
http://dx.doi.org/10.1128/JVI.02648-082009
Braidy N; Grant RS; Brew BJ; Adams S; Jayasena T; Guillemin GJ, 2009, 'Effects of Kynurenine Pathway Metabolites on Intracellular NAD+ Synthesis and Cell Death in Human Primary Astrocytes and Neurons', International Journal of Tryptophan Research : IJTR, vol. 2, pp. 61 - 69
2009
Joseph J; Clifford D; Douglas SD; Fox H; Gendelman HE; Gonzalez-Scarano F; Grant I; Major E; McArthur J, 2009, 'Planning Future Strategies for Domestic and International NeuroAIDS Research, July 24-25, 2008',
JOURNAL OF NEUROIMMUNE PHARMACOLOGY, vol. 4, pp. 283 - 297,
http://dx.doi.org/10.1007/s11481-009-9159-12009
Gray L; Roche M; Churchill MJ; Sterjovski J; Ellett A; Poumbourios P; Sherieff S; Wang B; Saksena N; Purcell DFJ; Wesselingh S; Cunningham AL; Brew BJ; Gabuzda D; Gorry PR, 2009, 'Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain (Journal of Virology (2009) 83, 11, (5430-5441))',
Journal of Virology, vol. 83, pp. 7794,
http://dx.doi.org/10.1128/JVI.01082-092009
Sher L; Cramer D; Grinyer J; Hall BM; Brayman K; Mirmira R, 2009, 'Editorial introductions', Current Opinion in Organ Transplantation, vol. 14
2009
Ting KK; Brew BJ; Guillemin GJ, 2009, 'Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease',
Journal of Neuroinflammation, vol. 6, pp. 1 - 13,
http://dx.doi.org/10.1186/1742-2094-6-362009
Churchill MJ; Wesselingh SL; Cowley D; Pardo CA; McArthur JC; Brew BJ; Gorry PR, 2009, 'Extensive astrocyte infection is prominent in human immunodeficiency virus - associated dementia',
Annals of Neurology, vol. 66, pp. 253 - 258,
http://dx.doi.org/10.1002/ana.216972009
Gisslén M; Krut J; Andreasson U; Blennow K; Cinque P; Brew BJ; Spudich S; Hagberg L; Rosengren L; Price RW; Zetterberg H, 2009, 'Amyloid and tau cerebrospinal fluid biomarkers in HIV infection',
BMC Neurology, vol. 9,
http://dx.doi.org/10.1186/1471-2377-9-632009
Braidy N; Grant RS; Adams S; Brew BJ; Guillemin GJ, 2009, 'Mechanism for quinolinic acid cytotoxicity in human astrocytes & neurons',
Neurotoxicity Research, vol. 16, pp. 77 - 86,
http://dx.doi.org/10.1007/s12640-009-9051-z2009
Maruff P; Thomas E; Cysique LA; Brew BJ; Collie A; Snyder P; Pietrzak R, 2009, 'Validity of the CogState Brief Battery: Relationship to Standardized Tests and Sensitivity to Cognitive Impairment in Mild Traumatic Brain Injury, Schizophrenia, and AIDS Dementia Complex',
Archives of Clinical Neuropsychology, vol. 24, pp. 165 - 178,
http://dx.doi.org/10.1093/arclin/acp0102009
Wright E; Brew BJ; Arayawichanont A; Robertson K; Samintharapanya K; Kongsaengdao S; Lim M; Vonthanak S; Lal L; Sarim C; Huffam SE; Li P; Imran D; Lewis J; Lun W; Kamarulzaman A; Tau G; Ali ST; Kishore K; Bain MA; Dwyer R; McCormack G; Hellard M; Cherry C; McArthur J; Wesselingh S, 2008, 'Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region',
Neurology, vol. 71, pp. 50 - 56,
http://dx.doi.org/10.1212/01.wnl.0000316390.17248.652008
Owe-Young R; Webster N; Mukhtar M; Pomerantz R; Smythe GA; Walker DW; Armati P; Crowe SM; Brew BJ, 2008, 'Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance & neurotoxicity',
Journal of Neurochemistry, vol. 105, pp. 1346 - 1357,
http://dx.doi.org/10.1111/j.1471-4159.2008.05241.x2008
Cherry C; Duncan A; Mackie K; Wesselingh S; Brew BJ, 2008, 'A Report on the Effect of Commencing Enfuvirtide on Peripheral Neuropathy',
AIDS Research and Human Retroviruses, vol. 24, pp. 1027 - 1030,
http://dx.doi.org/10.1089/aid.2007.03002008
Maneglier B; Guillemin GJ; Clayette P; Rogez-Kreuz C; Brew BJ; Dormont D; Advenier C; Therond P; Spreux-Varoquaux O, 2008, 'Serotonin decreases HIV-1 replication in primary cultures of human macrophages through 5-HT1A receptors',
British Journal of Pharmacology, vol. 154, pp. 174 - 182,
http://dx.doi.org/10.1038/bjp.2008.802008
Batmanian JJ; Lam M; Matthews C; Finckh A; Duffy M; Wright R; Brew BJ; Markus R, 2008, 'Reply', Medical Journal of Australia, vol. 188, pp. 489 - 490
2008
Wright E; Brew BJ; Lal L; Ali ST; Arayawichanont A; Imran D; Kamarulzaman A; Kongsaengdao S; Kruy L; Merati T; Samintharapanya K; Sarim C; Tau G; Thangsing C; Vin-Samnang C; Wesselingh S, 2008, 'Response to Birbeck et al',
Epilepsia, vol. 49, pp. 541 - 543,
http://dx.doi.org/10.1111/j.1528-1167.2007.01529_5.x2008
Ting KK; Brew BJ; Guillemin GJ, 2008, 'The involvement of astrocytes and kynurenine pathway in Alzheimer`s disease', Neurotoxicity Research, vol. 12, pp. 247 - 262
2008
Batmanian JJ; Lam MK; Matthews C; Finckh AS; Duffy MT; Wright RO; Brew BJ; Markus R, 2007, 'A protocol-driven model for the rapid initiation of stroke thrombolysis in the emergency department', Medical Journal of Australia, vol. 187, pp. 567 - 570
2007
Lim CK; Smythe GA; Stocker R; Brew BJ; Guillemin GJ, 2007, 'Characterization of the kynurenine pathway in primary human oligodendrocytes',
International Congress Series, vol. 1304, pp. 213 - 217,
http://dx.doi.org/10.1016/j.ics.2007.07.0112007
Croitoru-Lamoury J; Lamoury F; Zaunders J; Veas LA; Brew BJ, 2007, 'Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-beta, and Copaxone',
Journal of Interferon and Cytokine Research, vol. 27, pp. 53 - 64,
http://dx.doi.org/10.1089/jir.2006.00372007
Gisslen M; Hagberg L; Brew BJ; Cinque P; Price R; Rosengren L, 2007, 'Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex',
Journal of Infectious Diseases, vol. 195, pp. 1774 - 1778,
http://dx.doi.org/10.1086/5180432007
Cinque P; Brew BJ; Gisslen M; Hagberg L; Price RW, 2007, 'Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex',
Handbook of Clinical Neurology, vol. 85, pp. 261 - 300,
http://dx.doi.org/10.1016/S0072-9752(07)85017-22007
Gisslen M; Hagberg L; Rosengren L; Brew BJ; Cinque P; Spudich S; Price R, 2007, 'Defining and evaluating HIV-Related neurodegenerative disease and its treatment targets: A combinatorial approach to use of cerebrospinal fluid molecular biomarkers',
JOURNAL OF NEUROIMMUNE PHARMACOLOGY, vol. 2, pp. 112 - 119,
http://dx.doi.org/10.1007/s11481-006-9035-12007
Ting KK; Brew BJ; Guillemin GJ, 2007, 'Effect of Quinolinic acid on gene expression in human Astrocytes: Implications on Alzheimer’s disease',
International Congress Series, vol. 1304, pp. 384 - 388,
http://dx.doi.org/10.1016/j.ics.2007.07.0102007
Ting KK; Brew BJ; Guillemin GJ, 2007, 'The involvement of astrocytes and kynurenine pathway in Alzheimer`s disease',
Neurotoxicity Research, vol. 12, pp. 247 - 262,
http://dx.doi.org/10.1007/BF030339082007
Guillemin GJ; Brew BJ, 2007, 'Chronic HIV infection leads to an Alzheimer’s disease like illness - Involvement of the kynurenine pathway',
International Congress Series, vol. 1304, pp. 324 - 334,
http://dx.doi.org/10.1016/j.ics.2007.07.0312007
Thein H; Maruff P; Krahn M; Kaldor JM; Koorey D; Brew BJ; Dore GJ, 2007, 'Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-monoinfected and HIV/HCV-coinfected individuals commencing HCV treatment',
HIV Medicine, vol. 8, pp. 192 - 202,
http://dx.doi.org/10.1111/j.1468-1293.2007.00452.x2007
Drake A; Loy CT; Brew BJ; Chen TP; Petoumenos K; Li P; Wright E, 2007, 'Human immunodeficiency virus-associated progressive multifocal leucoencephalopathy: epidemiology and predictive factors for prolonged survival',
European Journal of Neurology, vol. 14, pp. 418 - 423,
http://dx.doi.org/10.1111/j.1468-1331.2007.01686.x2007
Guillemin GJ; Cullen K; Smythe GA; Kapoor V; Lim E; Garner B; Takikawa O; Brew BJ, 2007, 'Characterization of the kynurenine pathway in human neurons', Journal of the History of the Neurosciences, vol. 27, pp. 12884 - 12892
2007
Guillemin GJ; Cullen K; Lim C; Smythe GA; Garner B; Kapoor V; Takikawa O; Brew BJ, 2007, 'Characterization of the kynurenine pathway in human neurons',
Journal of Neuroscience, vol. 27, pp. 12884 - 12892,
http://dx.doi.org/10.1523/JNEUROSCI.4101-07.20072007
Brew BJ; Halman M; Catalan J; Sacktor N; Price R; Brown S; Atkinson H; Clifford D; Simpson D; Torres G; Hall C; Power C; Marder K; Mc Arthur J; Symonds W; Romero C, 2007, 'Factors in AIDS dementia complex trial design: Results and lessons from the abacavir trial',
PLoS Clinical Trials, vol. 2,
http://dx.doi.org/10.1371/journal.pctr.00200132007
Abdulle S; Mellgren A; Brew BJ; Cinque P; Hagberg L; Price R; Rosengren L; Gisslen M, 2007, 'CSF neurofilament protein (NFL) - a marker of active HIV-related neurodegeneration',
Journal of Neurology, vol. 254, pp. 1026 - 1032,
http://dx.doi.org/10.1007/s00415-006-0481-82007
Gorry P; Mcphee D; Verity E; Dyer W; Wesselingh S; Learmont J; Sullivan JS; Roche M; Zaunders J; Gabuzda D; Crowe S; Mills J; Lewin S; Brew BJ; Cunningham AL; Churchill M, 2007, 'Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo',
Retrovirology, vol. 4 (66),
http://dx.doi.org/10.1186/1742-4690-4-662007
Mellgren A; Price R; Hagberg L; Rosengren L; Brew BJ; Gisslen M, 2007, 'Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection',
Neurology, vol. 69 (15), pp. 1536 - 1541,
http://dx.doi.org/10.1212/01.wnl.0000277635.05973.552007
Guillemin GJ; Brew BJ; Noonan C; Knight TG; Cullen K, 2007, 'Mass spectrometric detection of quinolinic acid in microdissected Alzheimer disease plaques',
International Congress Series, vol. 1304, pp. 404 - 408,
http://dx.doi.org/10.1016/j.ics.2007.07.0122007
Cysique LA; Maruff P; Darby D; Brew BJ, 2006, 'The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery',
Archives of Clinical Neuropsychology, vol. 21, pp. 185 - 194,
http://dx.doi.org/10.1016/j.acn.2005.07.0112006
Shah M; Smit T; Morgello S; Tourtellotte W; Gelman B; Brew BJ; Saksena N, 2006, 'Env gp120 sequence analysis of HIV type 1 strains from diverse areas of the brain shows preponderance of CCR5 usage',
AIDS Research and Human Retroviruses, vol. 22, pp. 177 - 181,
http://dx.doi.org/10.1089/aid.2006.22.1772006
Cysique LA; Maruff P; Brew BJ, 2006, 'Valproic acid is associated with cognitive decline in HIV-infected individuals: a clinical observational study',
BMC NEUROLOGY, vol. 6, pp. 42 - 42,
http://dx.doi.org/10.1186/1471-2377-6-422006
Churchill MJ; Figueiredo A; Cowley D; Gray L; Purcell DFJ; Sullivan JS; McPhee DA; Wesselingh SL; Brew BJ; Gorry PR, 2006, 'Transcriptional activity of blood-and cerebrospinal fluid-derived nef/long-terminal repeat sequences isolated from a slow progressor infected with nef-deleted human immunodeficiency virus type 1 (HIV-1) who developed HIV-associated dementia',
Journal of NeuroVirology, vol. 12, pp. 219 - 228,
http://dx.doi.org/10.1080/135502806008273692006
Croitoru-Lamoury J; Williams K; Lamoury F; Veas LA; Ajami B; Taylor R; Brew BJ, 2006, 'Neural transplantation of human MSC and NT2 cells in the twitcher mouse model',
Cytotherapy, vol. 8, pp. 445 - 458,
http://dx.doi.org/10.1080/146532406008791522006
Guillemin GJ; Meininger V; Brew BJ, 2006, 'Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis (Review)',
Neurodegenerative Diseases, vol. 2, pp. 166 - 176,
http://dx.doi.org/10.1159/0000896222006
Lamoury F; Croitoru-Lamoury J; Brew BJ, 2006, 'Undifferentiated mouse mesenchymal stem cells spontaneously express neural and stem cell markers Oct-4 and Rex-1',
Cytotherapy, vol. 8, pp. 228 - 242,
http://dx.doi.org/10.1080/146532406007358752006
Cysique LA; Maruff P; Brew BJ, 2006, 'The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: A meta-analysis',
Journal of the International Neuropsychological Society, vol. 12, pp. 368 - 382,
http://dx.doi.org/10.1017/S13556177060604012006
Guillemin GJ; Kerr SJ; Brew BJ, 2005, 'Involvement of quinolinic acid in AIDS dementia complex',
Neurotoxicity Research, vol. 7, pp. 103 - 123,
http://dx.doi.org/10.1007/BF030337812005
Guillemin GJ; Brew BJ; Noonan C; Takikawa O; Cullen K, 2005, 'Indoleamine 2,3 dioxygenase and quinolinic acid in plaque and neurons in post-mortem brain tissue from Alzheimer`s disease and control cases', Neuropathology and Applied Neurobiology, vol. 31, pp. 395 - 404
2005
Cysique LA; Brew BJ; Halman M; Catalan J; Sacktor N; Price R; Brown S; Atkinson JH; Clifford D; Simpson D; Torres G; Hall C; Power C; Marder K; McArthur J; Symonds W; Romero C, 2005, 'Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients',
JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 39, pp. 426 - 429,
http://dx.doi.org/10.1097/01.qai.0000165799.59322.f52005
Winston A; Marriott D; Brew BJ, 2005, 'Early syphilis presenting as a painful polyradiculopathy in an HIV positive individual',
Sexually Transmitted Infections, vol. 81, pp. 133 - 134,
http://dx.doi.org/10.1136/sti.2004.0116682005
Guillemin GJ; Wang L; Brew BJ, 2005, 'Quinolinic acid induces apoptosis of human astrocyte', Journal of Neuroinflammation
2005
Guillemin GJ; Smythe GA; Takikawa O; Brew BJ, 2005, 'Expression of indoleamine 2,3 dioxygenase and production of quinolinic acid by human microglia, astrocytes and neurons', Glia, vol. 49, pp. 15 - 23
2005
Guillemin GJ; Smythe GA; Takikawa O; Brew BJ, 2005, 'Expression of indoleamine 2,3-dioxygenase and production of quinolinicacid by human microglia, astrocytes, and neurons',
Glia, vol. 49, pp. 15 - 23,
http://dx.doi.org/10.1002/glia.200902005
Brew B, 2005, 'Relativity and relativism [9]', New Scientist, vol. 188, pp. 27
2005
Guillemin GJ; Wang L; Brew BJ, 2005, 'Quinolinic acid selectively induces apoptosis of human astocytes: Potential role in AIDS dementia complex',
Journal of Neuroinflammation, vol. 2,
http://dx.doi.org/10.1186/1742-2094-2-162005
Guillemin GJ; Brew BJ; Noonan C; Takikawa O; Cullen K, 2005, 'Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer`s disease hippocampus',
Neuropathology and Applied Neurobiology, vol. 31, pp. 395 - 404,
http://dx.doi.org/10.1111/j.1365-2990.2005.00655.x2005
Batmanian J; Brew BJ, 2005, 'Clinical significance of central nervous system as sanctuary site for HIV', Journal of HIV therapy, vol. 10, pp. 16 - 21
2005
Brew BJ, 2004, 'Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex', AIDS, vol. 18 Suppl 1, pp. S75 - S78
2004
Smit T; Brew BJ; Tourtellotte W; Morgello S; Gelman B; Saksena NK, 2004, 'Independent evolution of human immunodeficiency virus (HIV) drugresistance mutations in diverse areas of the brain in HIV-infectedpatients, with and without dementia, on antiretroviral treatment',
Journal of Virology, vol. 78, pp. 10133 - 10148,
http://dx.doi.org/10.1128/JVI.78.18.10133-10148.20042004
Cysique LA; Maruff P; Brew BJ, 2004, 'Prevalence and pattern of neuropsychological impairment in humanimmunodeficiency virus-infected/acquired immunodeficiency syndrome(HIV/AIDS) patients across pre- and post-highly active antiretroviraltherapy eras: A combined study of two cohorts',
Journal of Neurovirology, vol. 10, pp. 350 - 357,
http://dx.doi.org/10.1080/135502804905210782004
Guillemin GJ; Brew BJ, 2004, 'Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification',
Journal of Leukocyte Biology, vol. 75, pp. 388 - 397,
http://dx.doi.org/10.1189/jlb.03031142004
Churchill M; Sterjovski J; Gray L; Cowley D; Chatfield C; Learmont J; Sullivan JS; Crowe SM; Mills J; Brew BJ; Wesselingh SL; McPhee DA; Gorry PR, 2004, 'Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementia',
Journal of Infectious Diseases, vol. 190, pp. 2181 - 2186,
http://dx.doi.org/10.1086/4255852004
Brew BJ; Pemberton LA; Ray J, 2004, 'Can the peripheral blood monocyte count be used as a marker of CSF resistance to antiretroviral drugs?', Journal of Neurovirology, vol. 10 Suppl 1, pp. 38 - 43
2004
Newell ME; Hoy JF; Cooper S; De Graaff B; Grulich AE; Bryant M; Millar JL; Brew BJ; Quinn DI, 2004, 'Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients',
Cancer, vol. 100, pp. 2627 - 2636,
http://dx.doi.org/10.1002/cncr.203002004
Guillemin GJ; Brew BJ, 2004, 'Phenotypic differences and similarities between microglia, macrophage and pericyte (review)', Journal of Leukocyte Biology, vol. 75, pp. 388 - 397
2004
Guillemin GJ; Smith DG; Smythe GA; Armati PJ; Brew BJ, 2003, 'Expression of the kynurenine pathway enzymes in human microglia and macrophages', Advances in Experimental Medicine and Biology, vol. 527, pp. 105 - 112
2003
Guillemin GJ; Croitoru-Lamoury J; Dormont D; Brew BJ, 2003, 'Involvement of quinolinic acid in chemokine production and chemokine receptor expression in human foetal astrocytes', Advances in Experimental Medicine and Biology, vol. 527, pp. 37 - 45
2003
Croitoru J; Guillemin GJ; Boussin F; Mognetti B; Gigout LI; Cheret A; Vaslin A; Le Grand AR; Brew BJ; Dormont J, 2003, 'Expressions of chemokines and their receptors in human and simian astrocytes: evidence for a central effect of TNF and IFN in CXCR4 and CCR5 modulation.',
Glia, vol. 41, pp. 354 - 370,
http://dx.doi.org/10.1002/glia.101812003
Guillemin GJ; Smythe GA; Veas LA; Takikawa O; Brew BJ, 2003, 'A1-42 induces production of quinolinic acid by human macrophages and microglia', NeuroReport, vol. 14, pp. 165 - 181
2003
Guillemin GJ; Croitoru J; Dormont J; Armati PJ; Brew BJ, 2003, 'Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes: implications for brain inflammation in AIDS', Glia, vol. 41, pp. 371 - 381
2003
Guillemin GJ; Smith DG; Armati PJ; Brew BJ, 2003, 'Expression kynurenine pathway enzymes in human macrophages and microglia', Advances in Experimental Medicine and Biology, vol. 527, pp. 105 - 112
2003
Dore GJ; McDonald AM; Li Y; Kaldor JM; Brew BJ, 2003, 'Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy',
AIDS, vol. 17, pp. 1539 - 1545,
http://dx.doi.org/10.1097/00002030-200307040-000152003
Guillemin GJ; Croitoru J; Dormont D; Armati PJ; Brew BJ, 2003, 'Involvement of quinolinic acid in chemokine production and chemokine receptor expression in human fœtal astrocytes', Glia, vol. 41, pp. 371 - 381
2003
Guillemin GJ; Smith DG; Williams KR; Smythe GA; Dormont D; Brew BJ, 2003, 'Quinolinic acid in the pathogenesis of Alzheimer’s disease', Advances in Experimental Medicine and Biology, vol. 527, pp. 167 - 176
2003
Croitoru-Lamoury J; Guillemin GJ; Dormont D; Brew BJ, 2003, 'Quinolinic acid up-regulates chemokine production and chemokinereceptor expression in astrocytes', Advances in Experimental Medicine and Biology, vol. 527, pp. 37 - 45
2003
Guillemin GJ; Croitoru-Lamoury J; Dormont D; Armati PJ; Brew BJ, 2003, 'Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes',
GLIA, vol. 41, pp. 371 - 381,
http://dx.doi.org/10.1002/glia.101752003
Brew BJ; Tisch S; Law MG, 2003, 'HIV nucleoside neuropathy and HIV distal symmetrical neuropathy: relationships to serum lactate and plasma HIV viral load', AIDS, vol. 17, pp. 1094 - 1096
2003
Guillemin GJ; Williams K; Smith DG; Smythe GA; Croitoru-Lamoury J; Brew BJ, 2003, 'Quinolinic acid in the pathogenesis of Alzheimer`s disease',
Advances in Experimental Medicine and Biology, vol. 527, pp. 167 - 176,
http://www.springer.com/series/55842003
Brew BJ, 2003, 'The peripheral nerve complications of human immunodeficiency virus (HIV) infection',
Muscle and Nerve, vol. 28, pp. 542 - 552,
http://dx.doi.org/10.1002/mus.104842003
Guillemin GJ; Smythe GA; Veas LA; Takikawa O; Brew BJ, 2003, 'A beta I-42 induces production of quinolinic acid by human macrophagesand microglia', Neuroreport, vol. 14, pp. 2311 - 2315
2003
Loy C; Brew BJ, 2002, 'Lymphona and opportunistic infections of the brain', Journal of Hiv Therapy, vol. 7, pp. 21 - 25
2002
Loy CT; Brew BJ, 2002, 'Treatment of opportunistic infections and lymphoma in the nervous system.', Journal of HIV therapy, vol. 7, pp. 21 - 25
2002
Smythe GA; Braga O; Brew BJ; Grant RS; Guillemin GJ; Kerr SJ; Walker DW, 2002, 'Concurrent quantification of quinolinic, picolinic and nicotinic acids using electron-capture negative-ion gas chromatography-mass spectrometry',
Analytical Biochemistry, vol. 301, pp. 21 - 26,
http://dx.doi.org/10.1006/abio.2001.54902002
Guillemin GJ; Brew BJ, 2002, 'Implications of the kynurenine pathway and quinolinic acid in Alzheimer`s disease', Redox Report, vol. 7, pp. 1
2002
Lanier ER; Sturge G; McClernon D; Brown S; Halman M; Sacktor N; McArthur J; Atkinson JH; Clifford D; Price R; Simpson D; Torres G; Catalan J; Marder K; Power C; Hall C; Romero C; Brew BJ, 2001, 'HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with abacavir',
AIDS, vol. 15, pp. 747 - 751,
http://dx.doi.org/10.1097/00002030-200104130-000102001
Smit T; Wang B; Ng T; Osborne R; Brew BJ; Saksena NK, 2001, 'Varied tropism of HIV-1 isolates derived from different regions of adult brain cortex discriminate between patients with and without AIDS Dementia Complex (ADC): evidence for neurotropic HIV variants.',
Virology, vol. 279, pp. 509 - 526,
http://dx.doi.org/10.1006/viro.2000.06812001
Smith DG; Guillemin GJ; Pemberton LA; Kerr SJ; Nath A; Smythe GA; Brew BJ, 2001, 'Quinolinic acid is produced by macrophages stimulated by platelet activating factor, NeF and Tat',
Journal of Neurovirology, vol. 7, pp. 56 - 60,
http://dx.doi.org/10.1080/1355028013000696922001
Guillemin GJ; Kerr SJ; Smythe GA; Smith DG; Kapoor V; Armati PJ; Croitoru J; Brew BJ, 2001, 'Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection',
Journal of Neurochemistry, vol. 78, pp. 842 - 853,
http://dx.doi.org/10.1046/j.1471-4159.2001.00498.x2001
Guillemin GJ; Kerr SJ; Pemberton LA; Smith DG; Smythe GA; Armati PJ; Brew BJ, 2001, 'IFN-b1b induces Kynurenine pathway metabolism in human macrophages:potential implications for multiple sclerosis treatment',
Journal of Interferon and Cytokine Research, vol. 21, pp. 1097 - 1101,
http://dx.doi.org/10.1089/1079990013172052312001
Guillemin GJ; Smith DD; Kerr SJ; Smythe GA; Kapoor V; Armati P; Brew BJ, 2000, 'Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neutopathogenesis', Redox Report, pp. 108 - 111
2000
Dore GJ; Brew BJ, 2000, 'Response to Eberly et al., Kaposi¿s sarcoma and central nervous system disease: a real association or an artifact of the control group? (letter)',
AIDS, vol. 14, pp. 2631 - 2632,
http://dx.doi.org/10.1097/00002030-200011100-000372000
Brew BJ; Dore GJ, 2000, 'Decreasing incidence of CNS AIDS defining events associated with antiretroviral therapy (letter)',
Neurology, vol. 55, pp. 1424 - 1424,
http://dx.doi.org/10.1212/WNL.55.9.14242000
Grulich AE; Dore GJ; Brew BJ, 2000, 'Human herpesvirus 8 and protection from AIDS dementia complex', Herpes, vol. 7, pp. 38 - 40
2000
Guillemin GJ; Smith DG; Kerr SJ; Smythe GA; Kapoor V; Armati P; Brew BJ, 2000, 'Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis',
Redox Report, vol. 5, pp. 108 - 111,
http://dx.doi.org/10.1179/1351000001015353752000
Cunningham PH; Smith DD; Satchell C; Cooper DA; Brew BJ, 2000, 'Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid.',
AIDS, vol. 14, pp. 1949 - 1954,
http://dx.doi.org/10.1097/00002030-200009080-000102000
Guillemin GJ; Kerr SJ; Smythe GA; Armati P; Brew BJ, 1999, 'Kynurenine pathway metabolism in human astrocytes', Advances in Experimental Medicine and Biology, vol. 467, pp. 125 - 131
1999
Brew BJ; Gisslen M; Svennerholm B; Fuchs D; Hagberg L, 1998, 'Neurological efficacy of stavudine, zidovudine, and lamivudine (multiple letters) [2]', Lancet, vol. 352, pp. 402 - 403
1998
Mcphee D; Greenway AL; Holloway G; Smith KR; Deacon N; Pemberton LA; Brew BJ, 1998, 'Anomalies in Nef expression within the central nervous system of HIV-1 positive individuals/AIDS patients with or without AIDS dementia complex',
Journal of Neurovirology, vol. 4, pp. 291 - 300,
http://dx.doi.org/10.3109/135502898091145301998
Szeto ER; Freund J; Brew BJ; Loder A; Griffiths M, 1998, 'Cerebral perfusion scanning in treating AIDS dementia', Journal of Nuclear Medicine, vol. 39, pp. 298 - 302
1998
Dore GJ; Grulich AE; Law MG; Brew BJ; Kaldor JM, 1998, 'Kaposi¿s sarcoma and protection from AIDS dementia complex', AIDS, vol. 12, pp. 2354 - 2355
1998
Brew BJ, 1998, 'Evaluation and management of intracranial mass lesions in AIDS - Report of the Quality Standards Subcommittee of the American Academy of Neurology', Neurology, vol. 51, pp. 1232 - 1233
1998
Cunningham AL; Naif H; Saksena N; Lynch G; Chang JW; Li S; Jozwiak R; Alali M; Wang B; Fear W; Sloane A; Pemberton LA; Brew BJ, 1997, 'HIV infection of macrophages and the pathogenesis of AIDS dementia complex: interaction of the host cell and viral genotype',
Journal of Leukocyte Biology, vol. 62, pp. 117 - 125,
http://dx.doi.org/10.1002/jlb.62.1.1171997
Dick AD; Pell MF; Brew BJ; Foulcher E; Sedgwick JD, 1997, 'Direct ex vivo flow cytometric analysis of human microglial cell CD4 expression: examination of central nervous system biopsy specimens from HIV-seropositive patients and patients with other neurological disease',
AIDS, vol. 11, pp. 1699 - 1708,
http://dx.doi.org/10.1097/00002030-199714000-000061997
Dore GJ; Law MG; Brew BJ, 1997, 'Prospective analysis of seizures occurring in human immunodeficiency virus type-1 infection',
Journal of Neuro-AIDS, vol. 1, pp. 59 - 69,
http://dx.doi.org/10.1300/J128v01n04_061997
Adcock JE; Davies MJ; Turner J; Pell MF; Brew BJ, 1997, 'Progressive multifocal leukoencephalopathy: a retrospective study of 30 cases',
Journal of Clinical Neuroscience, vol. 4, pp. 463 - 468,
http://dx.doi.org/10.1016/S0967-5868(97)90036-91997
Dunbar N; Pemberton L; Perdices M; Brew BJ, 1997, 'Clinical markers of the presence of dementia and neuropsychological impairment in hiv infection',
Journal of Neuro-AIDS, vol. 1, pp. 31 - 48,
http://dx.doi.org/10.1300/J128v01n04_041997
Kerr SJ; Armati P; Pemberton LA; Smythe GA; Tattam B; Brew BJ, 1997, 'Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages',
Neurology, vol. 49, pp. 1671 - 1681,
http://dx.doi.org/10.1212/WNL.49.6.16711997
Bradley TP; Brew BJ, 1997, 'HIV type-1-related transient neurologic deficits [2] (multiple letters)', American Journal of Medicine, vol. 103, pp. 250
1997
Pemberton LA; Kerr SJ; Smythe GA; Brew BJ, 1997, 'Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha',
Journal of Interferon and Cytokine Research, vol. 17, pp. 589 - 595,
http://dx.doi.org/10.1089/jir.1997.17.5891997
Markus R; Brew BJ; Turner J; Pell MF, 1997, 'Successful outcome with aggressive treatment of acute haemorrhagic leukoencephalitis',
Journal of Neurology Neurosurgery and Psychiatry, vol. 63, pp. 551 - 551,
http://dx.doi.org/10.1136/jnnp.63.4.5511997
Brew BJ; Pemberton LA; Cunningham PH; Law MG, 1997, 'Levels of human imunodeficiency virus type RNA in cerebrospinal fluid correlae with AIDS dementia stage',
Journal of Infectious Diseases, vol. 175, pp. 963 - 966,
http://dx.doi.org/10.1086/5140011997
Pemberton LA; Kerr SJ; Smythe GA; Brew BJ, 1997, 'Quinolinic acid production by macrophages stimulate with interferon y tumour necrosis factor a and interferon a', Journal of Interferon and Cytokine Research, vol. 17, pp. 589 - 595
1997
Dunbar N; Brew B, 1997, 'Neuropsychological Dysfunction in HIV Infection:A Review', Journal of neuro-AIDS, vol. 1, pp. 73 - 102
1997
Brew BJ; Glass JD; McArthur JC, 1996, 'Human immunodeficiency virus in brain and correlation with dementia [5]',
Annals of Neurology, vol. 39, pp. 828 - 829,
http://dx.doi.org/10.1002/ana.4103906311996
Brew BJ; Wesselingh SL; Gonzales M; Heyes MP; Price RW, 1996, 'Managing HIV. Part 3: Mechanisms of diseases. 3.7 How HIV leads to neurological disease.',
Med J Aust, vol. 164, pp. 233 - 234,
https://www.ncbi.nlm.nih.gov/pubmed/86041961996
Wright EJ; Brew BJ; Currie JN; McArthur JC, 1996, '5.4 HIV-induced neurological disease', Medical Journal of Australia, vol. 164, pp. 414 - 417
1996
Field AS; Marriot DJ; Milliken ST; Brew BJ; Canning EU; Kench JG; Darveniza P; Harkness JL, 1996, 'Myositis associated with a newly describes microsporidian Trachipleistophora hominis, in a patient with AIDS', Journal of Clinical Microbiology, vol. 34, pp. 2803 - 2811
1996
Jones PD; Beaman MH; Brew BJ, 1996, '5.5 HIV and opportunistic neurological infections', Medical Journal of Australia, vol. 164, pp. 418 - 421
1996
Brew BJ; Dunbar N; Druett J; Freund J; Ward PB, 1996, 'Pilot study of the efficacy of atervidine in ADC', AIDS, vol. 10, pp. 1357 - 1360
1996
Norton GR; Sweeney J; Marriott D; Law MG; Brew BJ, 1996, 'Association between HIV distal symmetric polyneuropathy and Mycobacterium avium complex infection',
Journal of Neurology Neurosurgery and Psychiatry, vol. 61, pp. 606 - 609,
http://dx.doi.org/10.1136/jnnp.61.6.6061996
Brew BJ; Wesselingh SL; Gonzales M; Heyes MP; Price RW, 1996, 'How HIV leads to neurological disease', Medical Journal of Australia, vol. 164, pp. 233 - 234
1996
Norton GR; Sweeney J; Marriott D; Law MG; Brew BJ, 1996, 'An association between HIV distal symmetrical polyneuropathy and Mycobacterium Avium complex infection', Journal of Neurology Neurosurgery and Psychiatry, pp. 606 - 609
1996
Brew BJ; Evans L; Byrne C; Pemberton LA; Hurren L, 1996, 'The relationship between AIDS demtia complex and the presence of macriphage tropic and non syncytium inducing isolates of human immunodeficiency virus type 1 in the cerebrospinal fluid',
Journal of Neurovirology, vol. 2, pp. 152 - 157,
http://dx.doi.org/10.3109/135502896091468771996
Brew BJ; Corbeil J; Pemberton LA; Evans L; Saito K; Penny R; Cooper DA; Heyes MP, 1996, 'Quinolinic acid production by macrophages infected with HIV-1 isolates from patients with and without AIDS dementia complex', Journal of Neurovirology, vol. 1, pp. 369 - 374
1996
Davies MJ; Pell MF; Brew BJ, 1995, 'Stereotectic biopsy of cerebral lesions in AIDS', Journal of Clinical Neuroscience, vol. 2, pp. 40 - 44
1995
Brew BJ; Rosenblum M; Cronin K; Price RW, 1995, 'AIDS dementia complex and HIV‐1 brain infection: Clinical‐virological correlations',
Annals of Neurology, vol. 38, pp. 563 - 570,
http://dx.doi.org/10.1002/ana.4103804041995
Brew BJ; Rosenblum M; Cronin K; Price R, 1995, 'The AIDS dementia complex and human immunodeficiency virus type 1 brian infection: clinical-virological correlations', Annals of Neurology, pp. 563 - 570
1995
Brew BJ; Corbeil J; Pemberton L; Evans L; Saito K; Penny R; Cooper DA; Heyes MP, 1995, 'Quinolinic acid production is related to macrophage tropic isolates of HIV-1.',
Journal of neurovirology, vol. 1, pp. 369 - 374,
http://dx.doi.org/10.3109/135502895091110261995
Davies MJ; Pell MF; Brew BJ, 1995, 'Stereotactic biopsy of cerebral lesions in AIDS', Journal of Clinical Neuroscience, vol. 2, pp. 40 - 44
1995
Brew BJ; Paul MO; Nakajima G; Khan A; Gallardo H; Price RW, 1994, 'Cerebrospinal fluid HIV-1 p24 antigen and culture: Sensitivity and specificity for AIDS-dementia complex',
Journal of Neurology, Neurosurgery and Psychiatry, vol. 57, pp. 784 - 789,
http://dx.doi.org/10.1136/jnnp.57.7.7841994
Milstien S; Sakai N; Brew BJ; Krieger C; Vickers JH; Saito K; Heyes MP, 1994, 'Cerebrospinal fluid nitrite/nitrate levels in neurologic diseases', Journal of Neurochemistry, vol. 63, pp. 1178 - 1180
1994
Brew BJ, 1994, 'HIV dementia', Neurology, vol. 44, pp. 2214
1994
Clezy K; Sirisanthana T; Sirisanthana V; Brew B; Cooper DA, 1994, 'Late manifestations of HIV in Asia and the Pacific', AIDS, vol. 8
1994
Kelleher AD; Brew BJ; Milliken ST, 1994, 'Intractable headache as the presenting complaint of AIDS-related lymphoma confined to bone', Journal of Acquired Immune Deficiency Syndromes, vol. 7, pp. 629 - 630
1994
Brew BJ; Currie JN, 1993, 'HIV-related neurological disease', Medical Journal of Australia, vol. 158, pp. 104 - 108
1993
Brew BJ; Miller J, 1993, 'Human immunodeficiency virus-related headache', Neurology, vol. 43, pp. 1098 - 1100
1993
Quinn D; Pocock N; Freund J; Kelleher A; Penny R; Brew B, 1993, 'Radionuclide hepatobiliary scanning in patients with AIDS-related sclerosing cholangitis',
Clinical Nuclear Medicine, vol. 18, pp. 417 - 422,
http://dx.doi.org/10.1097/00003072-199305000-000101993
Brew BJ, 1993, 'The pathogenesis of the neurological complications of HIV-1 infection', Genitourinary Medicine, vol. 69, pp. 333 - 340
1993
Shaskan EG; Brew BJ; Rosenblum M; Thompson RM; Price RW, 1992, 'Increased Neopterin Levels in Brains of Patients with Human Immunodeficiency Virus Type 1 Infection',
Journal of Neurochemistry, vol. 59, pp. 1541 - 1546,
http://dx.doi.org/10.1111/j.1471-4159.1992.tb08471.x1992
Carr A; Tindall B; Brew BJ; Marriott DJ; Harkness JL; Penny R; Cooper DA, 1992, 'Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS',
Annals of Internal Medicine, vol. 117, pp. 106 - 111,
http://dx.doi.org/10.7326/0003-4819-117-2-1061992
Rosenblum MK; Brew BJ; Hahn B; Shaw G; Haase A; Maroushek S; Price RW, 1992, 'Human T-lymphotropic virus type I-associated myelopathy in patients with the acquired immunodeficiency syndrome',
Human Pathology, vol. 23, pp. 513 - 519,
http://dx.doi.org/10.1016/0046-8177(92)90128-P1992
Heyes MP; Brew BJ; Saito K; Quearry BJ; Price RW; Lee K; Bhalla RB; Der M; Markey SP, 1992, 'Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and β2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients',
Journal of Neuroimmunology, vol. 40, pp. 71 - 80,
http://dx.doi.org/10.1016/0165-5728(92)90214-61992
Brew BJ; Bhalla RB; Paul M; Sidtis JJ; Keilp JJ; Sadler AE; Gallardo H; McArthur JC; Schwartz MK; Price RW, 1992, 'Cerebrospinal fluid β2-microglobulin in patients with AIDS dementia complex: An expanded series including response to zidovudine treatment', AIDS, vol. 6, pp. 461 - 465
1992
Kaplan JE; Litchfield B; Rouault C; Lairmore MD; Luo CC; Williams L; Brew BJ; Price RW; Janssen R; Stoneburner R; Ou CY; Folks T; De B, 1991, 'HTLV-I—associated myelopathy associated with blood transfusion in the United States: Epidemiologic and molecular evidence linking donor and recipient', Neurology, vol. 41, pp. 192 - 197
1991
Reimund E; Martin AA; Emerich DF; Sanberg PR; James Brew B; Everall I; Luthert P; Lantos P, 1991, 'Neuronal loss in frontal cortex in HIV infection',
The Lancet, vol. 338, pp. 129 - 130,
http://dx.doi.org/10.1016/0140-6736(91)90131-81991
Kaplan JE; Litchfield B; Rouault C; Lairmore MD; Luo CC; Williams L; Brew BJ; Price RW; Janssen R; Stoneburner R, 1991, 'HTLV-I-associated myelopathy associated with blood transfusion in the United States: epidemiologic and molecular evidence linking donor and recipient.',
Neurology, vol. 41, pp. 192 - 197,
http://dx.doi.org/10.1212/wnl.41.2_part_1.1921991
Janssen RS; Kaplan JE; Khabbaz RF; Hammond R; Lechtenberg R; Lairmore M; Chiasson MA; Punsalang A; Roberts B; Mc Kendall RR; Rosenblum M; Brew B; Farraye J; Howley DJ; Feraru E; Sparr S; Vecchio J; Silverman M; Mc Harg M; Gorin B; Rugg DR; Grenell S; Trimble B; Bruining K; Guha S; Amaraneni P; Price RW, 1991, 'HTLV–I—associated myelopathy/tropical spastic paraparesis in the United States', Neurology, vol. 41, pp. 1355 - 1357
1991
KAPLAN JE; LITCHFIELD B; ROUAULT C; LAIRMORE MD; LUO CC; WILLIAMS L; BREW BJ; PRICE RW; JANSSEN R; STONEBURNER R; OU CY; FOLKS T; DE B, 1991, 'HTLV-I ASSOCIATED MYELOPATHY ASSOCIATED WITH BLOOD-TRANSFUSION IN THE UNITED-STATES - EPIDEMIOLOGIC AND MOLECULAR EVIDENCE LINKING DONOR AND RECIPIENT',
NEUROLOGY, vol. 41, pp. 192 - 197,
http://dx.doi.org/10.1212/WNL.41.2_Part_1.1921991
Heyes MP; Brew B; Martin A; Markey SP; Price RW; Bhalla RB; Salazar A, 1991, 'Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome', Advances in Experimental Medicine and Biology, vol. 294, pp. 687 - 690
1991
Portegies P; Brew BJ, 1991, 'Update on HIV-related neurological illness.', AIDS (London, England), vol. 5 Suppl 2
1991
Heyes MP; Brew BJ; Martin A; Price RW; Salazar AM; Sidtis JJ; Yergey JA; Mouradian MM; Sadler AE; Keilp J; Rubinow D; Markey SP, 1991, 'Quinolinic acid in cerebrospinal fluid and serum in HIV‐1 Infection: Relationship to clinical and neurological status',
Annals of Neurology, vol. 29, pp. 202 - 209,
http://dx.doi.org/10.1002/ana.4102902151991
Price RW; Brew BJ; Rosenblum M, 1990, 'The AIDS dementia complex and HIV-1 brain infection: a pathogenetic model of virus-immune interaction.', Research publications - Association for Research in Nervous and Mental Disease, vol. 68, pp. 269 - 290
1990
Krown SE; Gold JWM; Niedzwiecki D; Bundow D; Flomenberg N; Gansbacher B; Brew BJ, 1990, 'Interferon-α with zidovudine: Safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)',
Annals of Internal Medicine, vol. 112, pp. 812 - 821,
http://dx.doi.org/10.7326/0003-4819-112-11-8121990
Brew BJ; Bhalla RB; Paul M; Gallardo H; McArthur JC; Schwartz MK; Price RW, 1990, 'Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection',
Annals of Neurology, vol. 28, pp. 556 - 560,
http://dx.doi.org/10.1002/ana.4102804131990
BREW BJ; PERDICES M; DARVENIZA P; EDWARDS P; WHYTE B; BURKE WJ; GARRICK R; O'SULLIVAN D; PENNY R; COOPER DA, 1989, 'THE NEUROLOGICAL FEATURES OF EARLY AND ‘LATENT’ HUMAN IMMUNODEFICIENCY VIRUS INFECTION',
Australian and New Zealand Journal of Medicine, vol. 19, pp. 700 - 705,
http://dx.doi.org/10.1111/j.1445-5994.1989.tb00339.x1989
Brew BJ; Bhalla RB; Fleisher M; Paul M; Khan A; Schwartz MK; Price RW, 1989, 'Cerebrospinal fluid β2microglobulin in patients infected with human immunodeficiency virus', Neurology, vol. 39, pp. 830 - 834
1989
Brew BJ; Hardy W; Zuckerman E; Chien N; Paul M; Rosenblum M; Gadler H; Vahlne A; Gold J; Armstrong DA; Price RW, 1989, 'AIDS‐related vacuolar myelopathy is not associated with coinfection by human T‐lymphotropic virus Type I',
Annals of Neurology, vol. 26, pp. 679 - 681,
http://dx.doi.org/10.1002/ana.4102605151989
Rosenblum M; Scheck AC; Cronin K; Brew BJ; Khan A; Pau M; Price RW, 1989, 'Dissociation of AIDS-related vacuolar myelopathy and productive HIV-1 infection of the spinal cord', Neurology, vol. 39, pp. 892 - 896
1989
Brew BJ, 1989, 'Acute encephalopathy caused by human immunodeficiency virus apparently responsive to zidovudine', Medical Journal of Australia, vol. 151, pp. 725 - 726
1989
PRICE RW; BREW B, 1988, 'Infection of the Central Nervous System by Human Immunodeficiency Virus Role of the Immune System in Pathogenesis',
Annals of the New York Academy of Sciences, vol. 540, pp. 162 - 175,
http://dx.doi.org/10.1111/j.1749-6632.1988.tb27059.x1988
Price RW; Brew B; Sidtis J; Rosenblum M; Scheck AC; Cleary P, 1988, 'The brain in AIDS: Central nervous system HIV-1 infection and AIDS dementia complex',
Science, vol. 239, pp. 586 - 592,
http://dx.doi.org/10.1126/science.32772721988
Brew BJ; Sidtis JJ; Rosenblum M; Price RW, 1988, 'AIDS dementia complex', Journal of the Royal College of Physicians of London, vol. 22, pp. 140 - 144
1988
Price RW; Brew B, 1988, 'Management of the neurologic complications of HIV infection and AIDS.', Infectious disease clinics of North America, vol. 2, pp. 359 - 372
1988
Aronow HA; Brew BJ; Price RW, 1988, 'The management of the neurological complications of HIV infection and AIDS', AIDS, vol. 2
1988
Brew BJ; Rosenblum M; Price RW, 1988, 'Pathogenetic implications of neuropathological findings in the AIDS dementia complex', Psychopharmacology Bulletin, vol. 24, pp. 307 - 310
1988
Brew BJ; Garrick R; Connelley TJ, 1987, 'Lumboperitoneal shunting as a cause of visual loss in benign intracranial hypertension.', Clinical and experimental neurology, vol. 23, pp. 233 - 235
1987
Brew BJ; Garrick R, 1987, 'Gliomas presenting outside the central nervous system.', Clinical and experimental neurology, vol. 23, pp. 111 - 117
1987
Brew BJ; O'Sullivan DJ; Darveniza P; Selby G; Fryer J; Evans W, 1987, 'Neoplastic angioendotheliosis.', Clinical and experimental neurology, vol. 23, pp. 119 - 126
1987
